Showing results (151-160 of 182) with videos related to
Sort By:
Pageof 19
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 22, 2019
[Urinary incontinence after HOLEP: Incidence, evolution and predictive factors]J Sapetti, J Sakat, E Saad, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 27, 2010
[New perspectives in prostate cancer management]L Boccon-Gibod, J-L Davin, C Coulange, et al.The Journal of Urology|October 5, 2001
Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 casesG De Pinieux, T Flam, M Zerbib, et al.Journal D'Urologie|January 1, 1993
[Urinary diversion by ureteral endoprosthesis during pregnancy]F N'Guebou, T Flam, N Thiounn, et al.Urology|August 1, 1997
Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastasesN Thiounn, F Saporta, T A Flam, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Update on the use of estramustin in metastatic prostate cancer]S Culine, L Drouet, J-C Eymard, et al.Journal D'Urologie|January 1, 1996
[Severe algoneurodystrophy of the right foot associated with prostatic cancer]M C Chefchaouni, C Francon, N Thiounn, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 1, 2011
[Healing and targeted therapies: Management in perioperative period?]G Pignot, T Lebret, D Chekulaev, et al.Journal D'Urologie|January 1, 1996
[Results of endorectal MRI in local staging of prostatic cancer. Correlation with specimens from prostatectomy. Apropos of 47 cases]M C Chefchaouni, T Flam, F Cornud, et al.British Journal of Urology|May 1, 1995
Lack of efficacy of low-dose subcutaneous recombinant interleukin-2 and interferon-alpha in the treatment of metastatic renal cell carcinomaN Thiounn, C Mathiot, T Dorval, et al.Pageof 19